Report Thumbnail
Product Code IW091401844HIV
Published Date 2021/12/14
English150 PagesEurope

EUROPE COSMETIC SURGERY AND PROCEDURE MARKET FORECAST 2022-2030Pharmaceutical_LifeSciense Market


Report Thumbnail
Product Code IW091401844HIV◆The Dec 2025 edition is also likely available. We will check with the publisher immediately.
Published Date 2021/12/14
English 150 PagesEurope

EUROPE COSMETIC SURGERY AND PROCEDURE MARKET FORECAST 2022-2030Pharmaceutical_LifeSciense Market



Abstract


Summary

KEY FINDINGS The Europe cosmetic surgery and procedure market is anticipated to register a CAGR of 5.46% across the forecasting years of 2022 to 2030. The regional market’s growth is reinforced by the increasing demand for Botox and dermal fillers, the rising need for non-invasive procedures from western European nations, and technical developments. MARKET INSIGHTS The Europe cosmetic surgery and procedure market growth evaluation comprises the assessment of Belgium, the United Kingdom, Italy, Germany, Poland, France, Russia, and Rest of Europe. Cosmetic surgery is proliferating in France, with procedures similar to those followed in the United States. The key difference between the two nations is of cosmetic augmentations as well as the legal ease with which patients undergo these procedures. Furthermore, botulinum toxin, breast augmentation, and filler treatment are among the major cosmetic surgeries observing increased demand in the country. In comparison, Italy ranks fourth in terms of cosmetic procedures across Europe. Besides, out of every 10 patients applying for cosmetic surgery in the country, one patient is a tourist. On account of the quality of medical facilities and services, people from neighboring and other nations, predominantly Switzerland, Romania, and Russia, visit Italy for cosmetic surgeries. In order to further facilitate foreign patients to the country, the Italian Association of Aesthetic Plastic Surgery (AICPE) signed an ‘aesthetic alliance’ with ISAPS for developing cosmetic surgeries, entailing high quality and offering improved patient safety. Therefore, these factors are expected to fuel the Europe cosmetic surgery and procedure market growth over the forecasted period. COMPETITIVE INSIGHTS Some of the top firms operating in the market are Galderma, Ipsen SA, Merz Pharma, etc. Our report offerings include: • Explore key findings of the overall market • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges) • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions • Market Segmentation cater to a thorough assessment of key segments with their market estimations • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc. • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc. • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Table of Contents

  • 1 RESEARCH SCOPE & METHODOLOGY

    • 1.1 STUDY OBJECTIVES
    • 1.2 SCOPE OF STUDY
    • 1.3 METHODOLOGY
    • 1.4 ASSUMPTIONS & LIMITATIONS
  • 2 EXECUTIVE SUMMARY

    • 2.1 MARKET SIZE & ESTIMATES
    • 2.2 MARKET OVERVIEW
  • 3 MARKET DYNAMICS

    • 3.1 KEY DRIVERS
      • 3.1.1 AGING POPULATION LEADS TO AN INCREASED DEMAND FOR ANTI-AGING COSMETIC AND AESTHETIC TREATMENTS
      • 3.1.2 RAPID GROWTH OF THE AESTHETIC INDUSTRY
      • 3.1.3 PREFERENCE FOR MINIMALLY INVASIVE AND NON-INVASIVE PROCEDURES OVER INVASIVE PROCEDURES
    • 3.2 KEY RESTRAINTS
      • 3.2.1 HIGH RATE OF AESTHETIC USAGES AND IMPLANTABLE MEDICAL DEVICES
      • 3.2.2 DIFFICULTIES RELATED TO COSMETIC TREATMENT
      • 3.2.3 SAFETY CONCERNS RELATED TO BREAST IMPLANT
  • 4 KEY ANALYTICS

    • 4.1 IMPACT OF COVID-19 ON COSMETIC SURGERY AND PROCEDURE MARKET
    • 4.2 KEY MARKET TRENDS
    • 4.3 PORTER’S FIVE FORCES ANALYSIS
      • 4.3.1 BUYERS POWER
      • 4.3.2 SUPPLIERS POWER
      • 4.3.3 NEW ENTRY
      • 4.3.4 SUBSTITUTIONS
      • 4.3.5 INDUSTRY RIVALRY
    • 4.4 VALUE CHAIN ANALYSIS
    • 4.5 REGULATORY FRAMEWORK
    • 4.6 OPPORTUNITY MATRIX
    • 4.7 VENDOR LANDSCAPE
  • 5 MARKET BY TYPE

    • 5.1 SURGICAL
      • 5.1.1 BREAST AUGMENTATION
      • 5.1.2 LIPOSUCTION
        • 5.1.2.1 LASER ASSISTED LIPOSUCTION
        • 5.1.2.2 RADIO FREQUENCY ASSISTED LIPOSUCTION
        • 5.1.2.3 ULTRASOUND ASSISTED LIPOSUCTION
        • 5.1.2.4 OTHER LIPOSUCTION SURGERIES
      • 5.1.3 EYELID SURGERY
      • 5.1.4 TUMMY TUCK
      • 5.1.5 BREAST LIFT
      • 5.1.6 OTHER SURGICAL TYPES
    • 5.2 NON-SURGICAL
      • 5.2.1 BOTULINUM TOXIN
      • 5.2.2 DERMAL FILLERS
      • 5.2.3 LASER HAIR REMOVAL
      • 5.2.4 CHEMICAL PEEL
      • 5.2.5 MICRODERMABRASION
      • 5.2.6 PHOTO-REJUVENATION
      • 5.2.7 OTHER NON-SURGICAL TYPES
  • 6 GEOGRAPHICAL ANALYSIS

    • 6.1 EUROPE
      • 6.1.1 MARKET SIZE & ESTIMATES
      • 6.1.2 KEY GROWTH ENABLERS
      • 6.1.3 KEY CHALLENGES
      • 6.1.4 KEY PLAYERS
      • 6.1.5 COUNTRY ANALYSIS
        • 6.1.5.1 GERMANY
        • 6.1.5.2 UNITED KINGDOM
        • 6.1.5.3 FRANCE
        • 6.1.5.4 ITALY
        • 6.1.5.5 RUSSIA
        • 6.1.5.6 BELGIUM
        • 6.1.5.7 POLAND
        • 6.1.5.8 REST OF EUROPE
  • 7 COMPETITIVE LANDSCAPE

    • 7.1 KEY STRATEGIC DEVELOPMENTS
      • 7.1.1 MERGERS & ACQUISITIONS
      • 7.1.2 PRODUCT LAUNCHES & DEVELOPMENTS
      • 7.1.3 PARTNERSHIPS & AGREEMENTS
      • 7.1.4 BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
    • 7.2 COMPANY PROFILES
      • 7.2.1 ALLERGAN PLC (ACQUIRED BY ABBVIE)
      • 7.2.2 ALMA LASERS LTD (ACQUIRED BY FOSUN PHARMA)
      • 7.2.3 BAUSCH HEALTH COMPANIES INC (FORMERLY VALEANT PHARMACEUTICALS)
      • 7.2.4 CANDELA CORP (FORMERLY SYNERON MEDICAL LTD)
      • 7.2.5 CUTERA INC
      • 7.2.6 CYNOSURE (ACQUIRED BY CLAYTON, DUBILIER & RICE)
      • 7.2.7 GALDERMA (ACQUIRED BY EQT)
      • 7.2.8 IPSEN SA
      • 7.2.9 JOHNSON & JOHNSON
      • 7.2.10 LUMENIS LTD
      • 7.2.11 MERZ PHARMA
      • 7.2.12 SIENTRA INC
      • 7.2.13 SINCLAIR PHARMA PLC
USD 1,600 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.